These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7840854)

  • 1. The bcl-2 proto-oncogene is overexpressed in systemic lupus erythematosus.
    Gatenby PA; Irvine M
    J Autoimmun; 1994 Oct; 7(5):623-31. PubMed ID: 7840854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential oncogene and TNF-alpha mRNA expression in bone marrow cells from systemic lupus erythematosus patients.
    Alvarado-de la Barrera C; Alcocer-Varela J; Richaud-Patin Y; Alarcón-Segovia D; Llorente L
    Scand J Immunol; 1998 Nov; 48(5):551-6. PubMed ID: 9822266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional overexpression of the proto-oncogene bcl-2 in patients with systemic Lupus erythematosus.
    Graninger WB
    Wien Klin Wochenschr; 1992; 104(7):205-7. PubMed ID: 1523845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High levels of bcl-2 protein in circulating T lymphocytes, but not B lymphocytes, of patients with systemic lupus erythematosus.
    Aringer M; Wintersberger W; Steiner CW; Kiener H; Presterl E; Jaeger U; Smolen JS; Graninger WB
    Arthritis Rheum; 1994 Oct; 37(10):1423-30. PubMed ID: 7945466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl-2 expression is unaltered in unfractionated peripheral blood mononuclear cells in patients with systemic lupus erythematosus.
    Rose LM; Latchman DS; Isenberg DA
    Br J Rheumatol; 1995 Apr; 34(4):316-20. PubMed ID: 7788144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus.
    Miret C; Font J; Molina R; Garcia-Carrasco M; Filella X; Ramos M; Cervera R; Ballesta A; Ingelmo M
    Anticancer Res; 2001; 21(4B):3053-9. PubMed ID: 11712810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogene expression in autoimmune mice.
    Mountz JD; Mushinski JF; Mark GE; Steinberg AD
    J Mol Cell Immunol; 1985; 2(3):121-31. PubMed ID: 3916923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the BCL-2 gene locus as a susceptibility locus linked to the clinical expression of systemic lupus erythematosus (SLE).
    Huang QR; Morris D; Manolios N
    Rheumatol Int; 1996; 16(3):121-4. PubMed ID: 8893377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases.
    Lorenz HM; Grünke M; Hieronymus T; Herrmann M; Kühnel A; Manger B; Kalden JR
    Arthritis Rheum; 1997 Feb; 40(2):306-17. PubMed ID: 9041943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive expression of bcl-2 in B cells causes a lethal form of lupuslike autoimmune disease after induction of neonatal tolerance to H-2b alloantigens.
    López-Hoyos M; Carrió R; Merino R; Buelta L; Izui S; Núñez G; Merino J
    J Exp Med; 1996 Jun; 183(6):2523-31. PubMed ID: 8676073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl-2 and Fas, molecules which influence apoptosis. A possible role in systemic lupus erythematosus?
    Rose LM; Latchman DS; Isenberg DA
    Autoimmunity; 1994; 17(4):271-8. PubMed ID: 7524704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional and post-transcriptional mechanisms are responsible for the increased expression of c-myc protooncogene in lymphocytes from patients with systemic lupus erythematosus.
    Eleftheriades EG; Boumpas DT; Balow JE; Tsokos GC
    Clin Immunol Immunopathol; 1989 Sep; 52(3):507-15. PubMed ID: 2474397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of the antiapoptotic gene Bfl-1 in B cells from patients with familial systemic lupus erythematosus.
    Andre J; Cimaz R; Ranchin B; Galambrun C; Bertrand Y; Bouvier R; Rieux-Laucat F; Trescol-Biemont MC; Cochat P; Bonnefoy-Berard N
    Lupus; 2007; 16(2):95-100. PubMed ID: 17402365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus.
    Mehrian R; Quismorio FP; Strassmann G; Stimmler MM; Horwitz DA; Kitridou RC; Gauderman WJ; Morrison J; Brautbar C; Jacob CO
    Arthritis Rheum; 1998 Apr; 41(4):596-602. PubMed ID: 9550468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo gene amplification in non-cancerous cells: cholinesterase genes and oncogenes amplify in thrombocytopenia associated with lupus erythematosus.
    Zakut H; Lapidot-Lifson Y; Beeri R; Ballin A; Soreq H
    Mutat Res; 1992 May; 276(3):275-84. PubMed ID: 1374519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased proto-oncogene expression in peripheral blood lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases.
    Boumpas DT; Tsokos GC; Mann DL; Eleftheriades EG; Harris CC; Mark GE
    Arthritis Rheum; 1986 Jun; 29(6):755-60. PubMed ID: 2424462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of p53 with other oncogenes, cytokines and systemic lupus erythematosus activity.
    Miret C; Molina R; Filella X; García-Carrasco M; Claver G; Ingelmo M; Ballesta A; Font J
    Tumour Biol; 2003; 24(4):185-8. PubMed ID: 14654712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and function of Fas antigen and bcl-2 in human systemic lupus erythematosus lymphocytes.
    Ohsako S; Hara M; Harigai M; Fukasawa C; Kashiwazaki S
    Clin Immunol Immunopathol; 1994 Oct; 73(1):109-14. PubMed ID: 7523011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactive oxygen species and the regulation of cell death by the Bcl-2 gene family.
    Korsmeyer SJ; Yin XM; Oltvai ZN; Veis-Novack DJ; Linette GP
    Biochim Biophys Acta; 1995 May; 1271(1):63-6. PubMed ID: 7599227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl-2 oncogene (B cell lymphoma/leukemia-2) levels correlate with systemic lupus erythematosus disease activity.
    Miret C; Font J; Molina R; Garcia-Carrasco M; Filella X; Ramos M; Cervera R; Ballesta A; Ingelmo M
    Anticancer Res; 1999; 19(4B):3073-6. PubMed ID: 10652595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.